1995 IPO
DaVita Stock
A leading provider of kidney care.
Sign up today and learn more about DaVita Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About DaVita Stock
DaVita a FORTUNE 500® company, is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2012, DaVita operated or provided administrative services at 1,884 outpatient dialysis centers located in the United States, serving approximately 149,000 patients. The company also operated 19 outpatient dialysis centers located in four countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.
Management
Senior Application Developer
Benjamin Snider
Interim Chief Financial Officer & Chief Accounting Officer
James Hilger
Chairman and CEO
Kent Thiry
IT Director
Jason Richling
Chief Compliance Officer
Jeanine Jiganti
Director, Strategy and Special Projects
Brannan Schell
Vice President of Clinical Affairs
John Wigneswaran
Chief Operating Officer
Joseph Mello
Press
New York Times - Aug, 2 2019
Top Kidney Charity Directed Aid to Patients at DaVita and Fresenius Clinics, Lawsuit ClaimsEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
